PDCD1 and colorectal carcinoma: Additional experiments verified that pre-treatment of cells with NUC-3373 caused increased cytotoxicity in CRC cells cocultured with PBMCs compared to both vehicle control and monoculture conditions and that addition of the anti-PD1 checkpoint inhibitor nivolumab causes further decrease in cell viability.